Refine by
Drug Treatment Suppliers & Manufacturers
70 companies found
based inBoston, MASSACHUSETTS (USA)
CervoMed is a clinical stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as ...
based inWendelsheim, GERMANY
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools. Our first objective is to demonstrate clinical proof-of-concept with our lead compound ...
Multiple System Atrophy (MSA) is a rare neurodegenerative disorder that belongs to the group of synucleinopathies and is also classified as an “atypical parkinsonism” disorder. Pathologically, MSA is characterized by abnormal deposits of ...
based inVienna, AUSTRIA
Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by ...
SLAMseq is a high-sensitivity method for time-resolved measurement of newly synthesized and existing RNA in cultured cells. SLAMseq enables resolution of RNA synthesis and degradation kinetics. Lexogen offers a family of kits based on the new ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Halofuginone (RU-19110) hydrobromid, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. Halofuginone hydrobromid is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) ...
based inReggio Emilia, ITALY
Founded in the Italian province of Reggio Emilia in 1997, Medi Nova started life as a laboratory conducting research on the provision of high-quality artificial swine insemination extenders for breeders, genetic companies and international boar ...
based inLindon, UTAH (USA)
The Company was founded in 2014 with a national corporate office and warehouse in Lindon, Utah and an office and warehouse in Ft. Pierce, Florida. We have developed non-invasive photomedicine technology that are used in medical professional ...
based inRye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
based inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
based inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
based inCalgary, ALBERTA (CANADA)
Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...
Hemostemix is currently conducting a randomized, double-blind, placebo-controlled Phase 2 clinical trial for patients with critical limb ischemia at sites in the Canada and United ...
based inSpringfield, NEW JERSEY (USA)
DRG International, Inc. is a leading manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries. DRG is also the manufacturer of the DRG:HYBRiD-XL, a fully automated analyzer for Immunoassays and Clinical ...
based inBerlin, GERMANY
Heartbeat Medical's outcome measurement platform and Real-World Data pools enable healthcare providers, payers, medical devices and pharmaceutical companies to evaluate how treatments impact patients’ quality of life. Over 200 hospital ...
based inShanghai, CHINA
Focusing on the core raw materials of the life science industry, Yeasen Biotechnology (Shanghai) Co., Ltd. is a biotechnology company engaged in the research and development, production and sales of three major categories of biological reagents: ...
D-luciferin is a common substrate for Luciferase and is widely used throughout biotechnology, especially in vivo imaging technology. The mechanism of action is that luciferin (the substrate) is oxidized to emit light in response to ATP and ...
based inCambridge, UNITED KINGDOM
Based in Cambridge, UK, Intelligent Fingerprinting specialises in the development of non-invasive, fingerprint-based diagnostic technology for use at point-of-care. The company has developed the world’s first portable fingerprint-based drug ...
based inMalvern, PENNSYLVANIA (USA)
Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease. ...
based inMiami, FLORIDA (USA)
Veru is a biotechnology company focused on developing novel medicines for COVID-19, additional ARDS-related diseases, and for breast and prostate cancers. Veru is a Wisconsin corporation and is the successor to The Wisconsin Pharmacal Company, Inc. ...
based inTübingen, GERMANY
HepaRegeniX GmbH is a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases. Since its start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inSan Diego, CALIFORNIA (USA)
OnsiteGene Inc. is a biomedical technology company spearheading the new era of super-fast on-site genetic testing in minutes based on a novel integrated sample prep and qPCR process. OnsiteGene is located in San Diego, California, USA. OnsiteGene's ...
based inNew York City, NEW YORK (USA)
Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain. ...
S1B-3006 is being developed to treat low desire and other sexual issues that are associated with a general medical condition. It is not uncommon for medical conditions to be accompanied by low desire. For example, low desire affects 90% of patients ...